These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

75 related articles for article (PubMed ID: 21429444)

  • 1. Highly activated oral bioavailability of tacrolimus on coadministration of oral voriconazole.
    Inoue Y; Saito T; Takimoto M; Ogawa K; Shibuya Y; Suzuki Y; Kato M; Takahashi M; Miura I; Hatta Y; Takeuchi J
    Int J Clin Pharmacol Ther; 2011 Apr; 49(4):291-2. PubMed ID: 21429444
    [No Abstract]   [Full Text] [Related]  

  • 2. Interaction between voriconazole and tacrolimus in a kidney-transplanted patient.
    Tintillier M; Kirch L; Goffin E; Cuvelier C; Pochet JM
    Nephrol Dial Transplant; 2005 Mar; 20(3):664-5. PubMed ID: 15735257
    [No Abstract]   [Full Text] [Related]  

  • 3. Voriconazole inhibition of tacrolimus metabolism.
    Pai MP; Allen S
    Clin Infect Dis; 2003 Apr; 36(8):1089-91. PubMed ID: 12684931
    [No Abstract]   [Full Text] [Related]  

  • 4. Drug interaction between voriconazole and tacrolimus and its association with the bioavailability of oral voriconazole in recipients of allogeneic hematopoietic stem cell transplantation.
    Mori T; Kato J; Yamane A; Sakurai M; Kohashi S; Kikuchi T; Ono Y; Okamoto S
    Int J Hematol; 2012 May; 95(5):564-9. PubMed ID: 22461034
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Switching from intravenous to oral tacrolimus and voriconazole leads to a more pronounced drug-drug interaction.
    Spriet I; Grootaert V; Meyfroidt G; Debaveye Y; Willems L
    Eur J Clin Pharmacol; 2013 Mar; 69(3):737-8. PubMed ID: 22878691
    [No Abstract]   [Full Text] [Related]  

  • 6. Voriconazole inhibition of tacrolimus metabolism in a kidney transplant recipient with fluconazole-resistant cryptococcal meningitis.
    Chang HH; Lee NY; Ko WC; Lee HC; Yang YH; Wu CJ; Chang CM
    Int J Infect Dis; 2010 Apr; 14(4):e348-50. PubMed ID: 19665407
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Experience with voriconazole in invasive aspergillosis].
    Thiel E; Schwartz S
    Mycoses; 2003; 46 Suppl 2():3-7. PubMed ID: 15055137
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical pharmacokinetics of voriconazole.
    Levêque D; Nivoix Y; Jehl F; Herbrecht R
    Int J Antimicrob Agents; 2006 Apr; 27(4):274-84. PubMed ID: 16563707
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Voriconazole, but not terbinafine, markedly reduces alfentanil clearance and prolongs its half-life.
    Saari TI; Laine K; Leino K; Valtonen M; Neuvonen PJ; Olkkola KT
    Clin Pharmacol Ther; 2006 Nov; 80(5):502-8. PubMed ID: 17112806
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An alternative approach to determine oral bioavailability of drugs that follow Michaelis-Menten elimination: a case study with voriconazole.
    Verlindo de Araujo B; Farias da Silva C; Costa TD
    Pharmacology; 2010; 86(3):163-7. PubMed ID: 20714206
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Drug interaction between voriconazole and tacrolimus in allogeneic hematopoietic SCT recipients.
    Mori T; Kato J; Yamane A; Ono Y; Shimizu T; Okamoto S
    Bone Marrow Transplant; 2011 Mar; 46(3):450-1. PubMed ID: 20453893
    [No Abstract]   [Full Text] [Related]  

  • 12. Clinically relevant drug interaction between voriconazole and tacrolimus in a primary renal allograft recipient.
    Kuypers DR; Claes K; Evenepoel P; Vanrenterghem Y
    Transplantation; 2006 Jun; 81(12):1750-2. PubMed ID: 16794545
    [No Abstract]   [Full Text] [Related]  

  • 13. Effect of oral itraconazole on the pharmacokinetics of tacrolimus in a hematopoietic stem cell transplant recipient with CYP3A5*3/*3.
    Nara M; Takahashi N; Miura M; Saitoh H; Kagaya H; Sawada K
    Am J Hematol; 2010 Aug; 85(8):634-5. PubMed ID: 20568249
    [No Abstract]   [Full Text] [Related]  

  • 14. Voriconazole inhibition of the metabolism of tacrolimus in a liver transplant recipient and in human liver microsomes.
    Venkataramanan R; Zang S; Gayowski T; Singh N
    Antimicrob Agents Chemother; 2002 Sep; 46(9):3091-3. PubMed ID: 12183280
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Voriconazole: a new triazole antifungal agent.
    Johnson LB; Kauffman CA
    Clin Infect Dis; 2003 Mar; 36(5):630-7. PubMed ID: 12594645
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacokinetics of voriconazole after oral and intravenous administration to horses.
    Davis JL; Salmon JH; Papich MG
    Am J Vet Res; 2006 Jun; 67(6):1070-5. PubMed ID: 16740104
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Voriconazole pharmacokinetic variability in cystic fibrosis lung transplant patients.
    Berge M; Guillemain R; Boussaud V; Pham MH; Chevalier P; Batisse A; Amrein C; Dannaoui E; Loriot MA; Lillo-Le Louet A; Billaud EM
    Transpl Infect Dis; 2009 Jun; 11(3):211-9. PubMed ID: 19302272
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacological aspects of the new triazole voriconazole.
    Ullmann AJ
    Ann Hematol; 2002; 81 Suppl 2():S50-1. PubMed ID: 12611077
    [No Abstract]   [Full Text] [Related]  

  • 19. Effects of voriconazole on tacrolimus metabolism in a kidney transplant recipient.
    Capone D; Tarantino G; Gentile A; Sabbatini M; Polichetti G; Santangelo M; Nappi R; Ciotola A; D'Alessandro V; Renda A; Basile V; Federico S
    J Clin Pharm Ther; 2010 Feb; 35(1):121-4. PubMed ID: 20175821
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Voriconazole.
    Naithani R; Kumar R
    Indian Pediatr; 2005 Dec; 42(12):1207-12. PubMed ID: 16424557
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.